Renal Failure, Acute
9
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Kidney Precision Medicine Project
The Efficacity of Hemodiafiltration Versus Hemofiltration for Renal Insufficiency During Intensive Care
Perioperative Use of Amino Acids in Recipients of Orthotopic Liver Transplantation as a Renal Protective Factor
Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation
Prevalence of Hypotension Associated With Preload Dependence During Continuous Renal Replacement Therapy
Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure
Sensitivity and Specificity of NGAL in an Emergency Room Population
Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)